LivaNova PLC
NASDAQ:LIVN

Watchlist Manager
LivaNova PLC Logo
LivaNova PLC
NASDAQ:LIVN
Watchlist
Price: 50.69 USD -2.05% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
LivaNova PLC?
Write Note

LivaNova PLC
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LivaNova PLC
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
LivaNova PLC
NASDAQ:LIVN
Retained Earnings
-$959.1m
CAGR 3-Years
-3%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Retained Earnings
$4.5B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Retained Earnings
ÂŁ50.9m
CAGR 3-Years
-13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Angle PLC
LSE:AGL
Retained Earnings
-ÂŁ121m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Retained Earnings
-ÂŁ132m
CAGR 3-Years
-29%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
Retained Earnings
-$10.1m
CAGR 3-Years
N/A
CAGR 5-Years
-55%
CAGR 10-Years
N/A
No Stocks Found

LivaNova PLC
Glance View

Market Cap
2.8B USD
Industry
Health Care

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The firm operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.

LIVN Intrinsic Value
81.23 USD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is LivaNova PLC's Retained Earnings?
Retained Earnings
-959.1m USD

Based on the financial report for Sep 30, 2024, LivaNova PLC's Retained Earnings amounts to -959.1m USD.

What is LivaNova PLC's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-29%

Over the last year, the Retained Earnings growth was 2%. The average annual Retained Earnings growth rates for LivaNova PLC have been -3% over the past three years , -29% over the past five years .

Back to Top